Multimorbidity and survival in older persons with colorectal cancer

Journal of the American Geriatrics Society

Volumn 54, Issue 12, 2006, Pages 1898-1904

  Gross, Cary P ^a,b   Guo, Zhenchao ^a   McAvay, Gail J ^a   Allore, Heather G ^a   Young, Mary ^a   Tinetti, Mary E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b YALE CANCER CENTER   (United States)

Author keywords

Cancer; Comorbidity; Epidemiology; Geriatrics; Multimorbidity

Indexed keywords

AGE; AGED; AGING; ARTICLE; CANCER MORTALITY; CANCER REGISTRY; CANCER SURVIVAL; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; COHORT ANALYSIS; COLORECTAL CANCER; COMORBIDITY; CONFIDENCE INTERVAL; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY;

AGED; AGED, 80 AND OVER; CAUSE OF DEATH; COLORECTAL NEOPLASMS; COMORBIDITY; FEMALE; GERIATRICS; HUMANS; MALE; REGISTRIES; RETROSPECTIVE STUDIES; SEER PROGRAM; SURVIVAL ANALYSIS; UNITED STATES;

EID: 33845494530     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/j.1532-5415.2006.00973.x     Document Type: Article

References (41)

1. McCormick WC, Boling PA. Multimorbidity and a comprehensive Medicare care-coordination benefit. J Am Geriatr Soc 2005;53:2227-2228.
2. Menotti A, Mulder I, Nissinen A et al. Prevalence of morbidity and multi-morbidity in elderly male populations and their impact on 10-year all-cause mortality: The FINE study (Finland, Italy, Netherlands, Elderly). J Clin Epidemiol 2001;54:680-686.
3. Tinetti ME, Bogardus ST Jr, Agostini JV. Potential pitfalls of disease-specific guidelines for patients with multiple conditions. N Engl J Med 2004;351:2870-2874.
4. Boyd CM, Darer J, Boult C et al. Clinical practice guidelines and quality of care for older patients with multiple comorbid diseases: Implications for pay for performance. JAMA 10 2005;294:716-724.
5. Kriegsman DM, Deeg DJ, Stalman WA. Comorbidity of somatic chronic diseases and decline in physical functioning: The Longitudinal Aging Study Amsterdam. J Clin Epidemiol 2004;57:55-65.
6. Wolff JL, Starfield B, Anderson G. Prevalence, expenditures, and complications of multiple chronic conditions in the elderly. Arch Intern Med 2002;162:2269-2276.
7. Wieland G.From Bench to Bedside: Research in Comorbidity and Aging [on-line]. Sci Aging Knowl Environ Available at http://sageke.sciencemag.org/ cgi/content/full/2005/39/pe29 Accessed June 2006
8. Yancik R, Wesley MN, Ries LA et al. Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: A population-based study. Cancer 1998;82:2123-2134.
9. Extermann M. Measurement and impact of comorbidity in older cancer patients. Crit Rev Oncol Hematol 2000;35:181-200.
10. Ries L, Eisner M, Kosary C et al. SEER Cancer Statistics Review, 1975-2002. National Cancer Institute. Available at http://seer.cancer.gov/csr/ 1975_2002/ Accessed February 28, 2006.
11. National Institute on Aging, National Cancer Institute. Exploring the Role of Cancer Centers for Integrating: Aging and Cancer. Workshop Report. June 11-13, 2001, Bethesda, MD.
12. Tammemagi CM, Nerenz D, Neslund-Dudas C et al. Comorbidity and survival disparities among black and white patients with breast cancer. JAMA 2005;294:1765-1772.
13. Extermann M. Studies of comprehensive geriatric assessment in patients with cancer. Cancer Control 2003;10:463-468.
14. Rijken M, van Kerkhof M, Dekker J et al. Comorbidity of chronic diseases: Effects of disease pairs on physical and mental functioning. Qual Life Res 2005;14:45-55.
15. Fleming ST, Rastogi A, Dmitrienko A et al. A comprehensive prognostic index to predict survival based on multiple comorbidities: A focus on breast cancer. Med Care 1999;37:601-614.
16. Yancik R, Ganz PA, Varricchio CG et al. Perspectives on comorbidity and cancer in older patients: Approaches to expand the knowledge base. J Clin Oncol 2001;19:1147-1151.
17. Schrag D, Gelfand SE, Bach PB et al. Who gets adjuvant treatment for stage II and III rectal cancer? Insight from surveillance, epidemiology, and end results. Med J Clin Oncol 2001;19:3712-3718.
18. Schrag D, Cramer LD, Bach PB et al. Age and adjuvant chemotherapy use after surgery for stage III colon cancer. J Natl Cancer Inst 2001;93:850-857.
19. Read WL, Tierney RM, Page NC et al. Differential prognostic impact of comorbidity. J Clin Oncol 2004;22:3099-3103.
20. Piccirillo JF, Tierney RM, Costas I et al. Prognostic importance of comorbidity in a hospital-based cancer registry. JAMA 2004;291:2441-2447.
21. Ries L, Kosary C, Hankey B et al., eds. SEER Cancer Statistics Review. Bethesda, MD: National Cancer Institute, 1999.
22. Bach PB, Guadagnoli E, Schrag D et al. Patient demographic and socioeconomic characteristics in the SEER-Medicare database applications and limitations. Med Care 2002;40(8 Suppl):19-25.
23. Cooper GS, Payes JD. Receipt of colorectal testing prior to colorectal carcinoma diagnosis. Cancer 2005;103:696-701.
24. Klabunde CN, Potosky AL, Legler JM et al. Development of a comorbidity index using physician claims data. J Clin Epidemiol 2000;53:1258-1267.
25. Hebert PL, Geiss LS, Tierney EF et al. Identifying persons with diabetes using Medicare claims data. Am J Med Qual 1999;14:270-277.
26. Lamont EB, Lauderdale DS, Schilsky RL et al. Construct validity of Medicare chemotherapy claims: The case of 5FU. Med Care 2002;40:201-211.
27. Hosmer D, Lemeshow S, eds. Applied Survival Aanlysis. Regression Modeling of Time to Even Data. New York: John Wiley & Sons, 1999.
28. Keating NL, Landrum MB, Ayanian JZ et al. The association of ambulatory care with breast cancer stage at diagnosis among Medicare beneficiaries. J Gen Intern Med 2005;20:38-44.
29. Rockhill B, Newman B, Weinberg C. Use and misuse of population attributable fractions. Am J Public Health 1998;88:15-19.
30. Engel LS, Chow WH, Vaughan TL et al. Population attributable risks of esophageal and gastric cancers. J Natl Cancer Inst 2003;95:1404-1413.
31. Hanley JA. A heuristic approach to the formulas for population attributable fraction. J Epidemiol Community Health 2001;55:508-514.
32. Moritz DJ, Ostfeld AM, Blazer D 2nd et al. The health burden of diabetes for the elderly in four communities. Public Health Rep 1994;109:782-790.
33. Qiao Q, Hu G, Tuomilehto J et al. Age- and sex-specific prevalence of diabetes and impaired glucose regulation in 11 Asian cohorts. Diabetes Care 2003;26:1770-1780.
34. Petty TL. Scope of the COPD problem in North America. Early studies of prevalence and NHANES III data: Basis for early identification and intervention. Chest 2000;117(5 Suppl 2):326S-331S.
35. Rockwood K, Awalt E, MacKnight C et al. Incidence and outcomes of diabetes mellitus in elderly people: Report from the Canadian Study of Health and Aging. Can Med Assoc J 2000;162:769-772.
36. Ouellette JR, Small DG, Termuhlen PM. Evaluation of Charlson-Age Comorbidity Index as predictor of morbidity and mortality in patients with colorectal carcinoma. J Gastrointest Surg 2004;8:1061-1067.
37. Eley JW, Hill HA, Chen VW et al. Racial differences in survival from breast cancer. Results of the National Cancer Institute Black/White Cancer Survival Study. JAMA 1994;272:947-954.
38. Quan H, Parsons GA, Ghali WA. Validity of information on comorbidity derived from ICD-9-CCM administrative data. Med Care 2002;40:675-685.
39. Gross CP, Herrin J, Wong N et al. Enrolling older persons in cancer trials: The effect of sociodemographic, protocol, and recruitment center characteristics. J Clin Oncol 2005;23:4755-4763.
40. Braunstein JB, Anderson GF, Gerstenblith G et al. Noncardiac comorbidity increases preventable hospitalizations and mortality among Medicare bene-ficiaries with chronic heart failure. J Am Coll Cardiol 2003;42:1226-1233.
41. Seo PH, Pieper CF, Cohen HJ. Effects of cancer history and comorbid conditions on mortality and healthcare use among older cancer survivors. Cancer 2004;101:2276-2284.